A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The principal excitatory neurotransmitter in the vertebrate central nervous system, L-glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA (N-methyl-D-aspartate) and kainate. The development of selective pharmacological agents has led to a detailed understanding of the physiological and pathological roles of AMPA and NMDA receptors. In contrast, the lack of selective kainate receptor ligands has greatly hindered progress in understanding the roles of kainate receptors. Here we describe the effects of a potent and selective agonist, ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid), of the GluR5 subtype of kainate receptor. We have used these agents to show that kainate receptors, comprised of or containing GluR5 subunits, regulate synaptic inhibition in the hippocampus, an action that could contribute to the epileptogenic effects of kainate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hippocampus, exogenous kainate reduces the amplitude and Pr of evoked IPSCs onto CA1 pyramidal cells (208, 231, 734, 951) (however cf. with Refs. 231, 332).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [208]
Citations
Cites
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491 · cited 1×
“gif" NDATA ITEM> ]> The principal excitatory neurotransmitter in the vertebrate central nervous system, L -glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (α-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA ( N -methyl- D -aspartate) and kainat”
BackgroundMonaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Excitatory amino acid receptors in the vertebrate central nervous system.
Collingridge, G. L., & Lester, R. A. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00025-0 · Cited by 1,341
Self-citationBettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E. S., Moll, C., Borgmeyer, U., Hollmann, M., & Heinemann, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90213-y · Cited by 649 · cited 1×
“Here we describe the effects of a potent and selective agonist, ATPA (( RS )-2-amino-3-(3-hydroxy-5- tert -butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid),…”
BackgroundPartin, K. M., Patneau, D. K., Winters, C. A., Mayer, M. L., & Buonanno, A. (1993) · Neuron · doi:10.1016/0896-6273(93)90220-l · Cited by 583
Bettler, B., & Mulle, C. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00141-e · Cited by 456
Huettner, J. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90163-a · Cited by 420 · cited 1×
“Currents activated by kainate in acutely isolated dorsal root ganglion (DRG) neurons are thought to be mediated by GluR5 receptor”
BackgroundRegulation of glutamate release by presynaptic kainate receptors in the hippocampus
Chittajallu, R., Vignes, M., Dev, K. K., Barnes, J. M., Collingridge, G. L., & Henley, J. M. (1996) · Nature · doi:10.1038/379078a0 · Cited by 394 · cited 1×
“GYKI53655 (LY300168) was used to eliminate AMPA receptor-mediated synaptic transmission while preserving functional kainate receptor”
MethodSelf-citation
Research works printed but not linked: 2
- Seeburg, P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 14, 297–303 (1993).
- Bleakman, D. et al. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3 S, 4a R, 6 R, 8a R)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic-acid. Mol. Pharmacol. 49, 581–585 (1996).
Cited by
Items 201–300 of 427
Lu, C., Willcockson, H. H., Phend, K. D., Lucifora, S., Darstein, M., Valtschanoff, J. G., & Rustioni, A. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20525 · Cited by 44
“…release of GABA by activation of presynaptic kainate receptors were reported in the hippocampus, basolateral amygdala, and ventrobasal thalamus (Clarke et al., 1997; Rodriguez-Moreno et al., 1997; Min et al., 1999; Cossart et al., 2001; Jiang et al., 2001; Binns et al., 2003; Braga et al.,…”
BackgroundKieval, J. Z., Hubert, G. W., Charara, A., Paré, J., & Smith, Y. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08746.2001 · Cited by 39
“Interestingly, several in vitro electrophysiological and pharmacological studies have shown that KARS mediate presynaptic effects on GABAergic and glutamatergic neurotransmission in various brain regions (Clarke et al., 1997; Lerma et al., 1997; Rodriguez-Moreno et al., 1997; Mulle et al., 1998; Rodriguez-Moreno and L…”
Zilberter, Y., Harkany, T., & Holmgren, C. D. (2005) · The Neuroscientist · doi:10.1177/1073858405275827 · Cited by 38
Metabotropic Actions of Kainate Receptors in the Control of GABA Release
Sihra, T. S., & Moreno, A. R. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9557-5_1 · Cited by 42
Glycine release in the substantia nigra: Interaction with glutamate and GABA
Dopico, J. G., González‐Hernández, T., Pérez, I. M., García, I. G., Abril, A. M., Obeso, J. A., & Rodríguez, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.014 · Cited by 38
Kahlem, P. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9053-z · Cited by 39
Christensen, J. K., Varming, T., Ahring, P. K., Jørgensen, T. D., & Nielsen, E. Ø. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062794 · Cited by 40
“, 1985) is a GLUK5-preferring agonist potently activating homomeric GLUK5 receptors and native dorsal root ganglion kainate receptors, but shows only weak activity at AMPA receptors, and no activity at GLUK6 homomers (Clarke et al., 1997; Wilding and Huettner, 2001).”
BackgroundWahl, P., Anker, C., Traynelis, S. F., Egebjerg, J., Rasmussen, J. S., Krogsgaard‐Larsen, P., & Madsen, U. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.590 · Cited by 40
“The latter activity is interesting in relation to a very recent letter in Nature (Clarke et al., 1997), describing the AMPA agonist (R,S)-2amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid to be a potent agonist at GluR5.”
BackgroundInhibition of Kainate Receptors Reduces the Frequency of Hippocampal Theta Oscillations
Huxter, J. R., Zinyuk, L. E., Roloff, E. V. L., Clarke, V. R. J., Dolman, N. P., More, J. C. A., Jane, D. E., Collingridge, G. L., & Muller, R. U. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3954-06.2007 · Cited by 36
“1D) caused by activation of GLUK5 receptors on inhibitory interneurons (Clarke et al., 1997); this was done after blockade of both AMPA and NMDA receptor-mediated components of glutamatergic transmission.”
BackgroundSelf-citationMedicinal Chemistry of Competitive Kainate Receptor Antagonists
Larsen, A. M., & Bunch, L. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn1001039 · Cited by 38
Mathew, S. S., & Hablitz, J. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.005 · Cited by 38
“In contrast to previous studies showing IPSC depression (Clarke et al., 1997; Rodriguez-Moreno et al., 1997; Frerking et al., 1998; Min et al., 1999; Ali et al., 2001; Cossart et al., 2001), we observe facilitatory effects of KA on IPSCs.”
BackgroundResultCornil, C. A., Foidart, A., Minet, A., & Balthazart, J. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001225)428:4<577::aid-cne1>3.0.co;2-k · Cited by 36
Differential Regulation of Glutamate Receptors in Alzheimer’s Disease
Lee, H., Zhu, X., Ghanbari, H. A., Ogawa, O., Raina, A. K., O'Neill, M. J., Perry, G. L., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067427 · Cited by 37
Kainate receptor-dependent presynaptic modulation and plasticity
Kamiya, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(01)00303-0 · Cited by 39
Brill, J., & Huguenard, J. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6098-08.2009 · Cited by 35
“, 2007) or inhibition (Clarke et al., 1997; Ali et al., 2001; Jin and Smith, 2007) of GABAergic neurotransmission.”
BackgroundInfluentialKainate receptor pharmacology and physiology
Bleakman, D. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050453 · Cited by 44
Self-citationInhibition of rat neuronal kainate receptors by cis‐unsaturated fatty acids
Wilding, T. J., Chai, Y. H., & Huettner, J. E. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.331bb.x · Cited by 35
Taxidis, J., Coomber, B., Mason, R., & Owen, M. R. (2010) · Biological Cybernetics · doi:10.1007/s00422-010-0370-1 · Cited by 36
“Alternatively, a removal of inhibition at interneurone-pyramidal cell synapses may also be involved (Clarke et al. 1997; Rodríguez-Moreno et al. 1997; Maingret et al. 2005).”
Evanson, N. K., Van Hooren, D. C., & Herman, J. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.011 · Cited by 34
“In the hippocampus, for example, GluR5 is found presynaptically (Pinheiro et al., 2005), and presynaptic GluR5-mediated signaling leads to decreased excitatory activity (Clarke et al., 1997).”
BackgroundTrafficking and surface expression of the glutamate receptor subunit, KA2
Hayes, D. M., Braud, S., Hurtado, D. E., McCallum, J. D., Standley, S., Isaac, J. T. R., & Roche, K. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.115 · Cited by 36
Ziakopoulos, Z., Brown, M. W., & Bashir, Z. I. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00965.x · Cited by 38
Orav, E., Atanasova, T., Shintyapina, A. B., Kesaf, S., Kokko, M., Partanen, J. M., Taira, T., & Lauri, S. E. (2017) · eNeuro · doi:10.1523/eneuro.0048-17.2017 · Cited by 38
“Absence of tonic KAR activity in Neto1 / slices is due to loss of functional presynaptic KARs NETO interaction increases the agonist sensitivity of GluK1 KARs (Fisher, 2015; Li et al., 2016).”
MethodBloss, E. B., & Hunter, R. G. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82009-6 · Cited by 53
[3H]ATPA: a high affinity ligand for GluR5 kainate receptors
Hoo, K. H., Legutko, B., Rizkalla, G., Deverill, M., Hawes, C. R., Ellis, G. J., Stensbøl, T. B., Krogsgaard‐Larsen, P., Skolnick, P., & Bleakman, D. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00133-1 · Cited by 34
Self-citationMorishita, W., & Alger, B. E. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.5.2556 · Cited by 35
“KA serves as a very important control in this case because, although it is a glutamate agonist and antagonizes evoked IPSCs (Clarke et al. 1997; Cossart et al. 1998; Fisher and Alger 1984; Frerking et al. 1998; Rodriguez-Moreno et al. 1997) at a presynaptic site linked to a G-protein…”
Antagonism of neuronal kainate receptors by lanthanum and gadolinium
Huettner, J. E., Stack, E., & Wilding, T. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00082-3 · Cited by 33
“More recently, kainate receptors have attracted wide attention as potential mediators of both presynaptic (Chittajallu et al., 1996; Clarke et al., 1997; Rodriguez-Moreno et al., 1997) and postsynaptic (Castillo et al.”
BackgroundAberrant glutamate receptor 5 expression in temporal lobe epilepsy lesions
Li, J., Zeng, Y., Peng, F., Li, L., Yang, T., Hong, Z., Lei, D. J., Chen, Z., & Zhou, D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.024 · Cited by 41
Kainate receptors in the developing neuronal networks
Lauri, S. E., Ryazantseva, M., Orav, E., Vesikansa, A., & Taira, T. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108585 · Cited by 35
“GluK1 subunit containing KARs also regulate GABA release in a variety of interneuron subtypes both during development and in the adults (e.g. Clarke et al., 1997; Maingret et al., 2005; Daw et al., 2010; Lourenco et al., 2010).”
Dimpfel, W., & Hoffmann, J. (2011) · BMC Pharmacology · doi:10.1186/1471-2210-11-2 · Cited by 33
“(S-Fluorowillardiine; [17-19]), (RS)-2-Amino-3-(3hydroxy-5-tert-butyliosxazol-4-yl)propanoic acid (ATPA; [20-23]) and (±)-1-Aminocyclopentane-trans-1,3-dicarboxylic acid (t-ACPD; [24-26]).”
Kainate receptors: an interplay between excitatory and inhibitory synapses
Lerma, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00462-1 · Cited by 32
Lee, C. J., Labrakakis, C., Joseph, D. J., & MacDermott, A. B. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.015 · Cited by 31
M�ller, E. H., Egebjerg, J., Brehm, L., Stensb�l, T. B., Johansen, T. N., Madsen, U., & Krogsgaard‐Larsen, P. (1999) · Chirality · doi:10.1002/(sici)1520-636x(1999)11:10<752::aid-chir3>3.0.co;2-t · Cited by 31
Potschka, H., Löscher, W., Właź, P., Behl, B., Hofmann, H. P., Treiber, H., & Szabo, L. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702172 · Cited by 31
“…antagonist for the GluR5 subtype of kainate receptors, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6((((1H-tetrazol-5-yl)methyl)oxy)methyl)-1,2,3,4,4a,5,6,7,8,8adecahydroisoquinoline-3-carboxylic acid), has been described (Clarke et al., 1997), but this compound has not yet been tested in seizure models.”
BackgroundMethodUllal, G. R., Fahnestock, M. L., & Racine, R. J. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.49604.x · Cited by 30
CA3 Synaptic Silencing Attenuates Kainic Acid-Induced Seizures and Hippocampal Network Oscillations
Yu, L. M. Y., Polygalov, D., Wintzer, M. E., Chiang, M.-C., & McHugh, T. J. (2016) · eNeuro · doi:10.1523/eneuro.0003-16.2016 · Cited by 36
“…depression of inhibitory transmission in CA1 could play a crucial role in epileptiform activity, a “collapse of inhibition” model (Fisher and Alger, 1984; Clarke et al., 1997; Rodríguez-Moreno and Lerma, 1998), our results suggest this action of the drug alone is insufficient to induce seizure.”
ResultCaiati, M. D., Sivakumaran, S., & Cherubini, E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4566-09.2010 · Cited by 35
“In contrast to UBP 302, pharmacological activation of GluK1 receptors with ATPA (1 M), a selective GluK1 agonist (Clarke et al., 1997), reversibly decreased the amplitude of MF-GPSCs (from 54 9 to 22 4 pA; n 11; p 0.”
BackgroundResultAl‐Ubaidi, M. R., White, T. W., Ripps, H., Poras, I., Avner, P., Gomès, D., & Bruzzone, R. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000315)59:6<813::aid-jnr14>3.0.co;2-# · Cited by 109
Savidge, J. R., & Bristow, D. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00280-5 · Cited by 29
Presynaptic glutamate receptors in nociception
Xie, R., Xu, G., Wu, S., & Luo, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108539 · Cited by 30
Apland, J. P., Aroniadou‐Anderjaska, V., & Braga, M. F. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.053 · Cited by 28
Glial–neuronal interactions following kainate injection in rats
Qu, H., Eloqayli, H., Müller, B., Aasly, J. O., & Sonnewald, U. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00051-7 · Cited by 28
Jäck, A., Hamad, M. I. K., Gonda, S., Gralla, S., Pahl, S., Hollmann, M., & Wahle, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1414-0 · Cited by 31
Ghersi, C., Bonfanti, A., Manzari, B., Feligioni, M., Raiteri, M., & Pittaluga, A. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00129-8 · Cited by 28
Kainate receptors: knocking out plasticity
Huettner, J. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01830-0 · Cited by 32
Nagy, D., Kocsis, K., Fuzik, J., Marosi, M., Kis, Z., Teichberg, V. I., Toldi, J., & Farkas, T. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.005 · Cited by 27
“, 2000), while another population of kainate receptors depress evoked inhibitory postsynaptic currents and GABA release through a G-protein-dependent mechanism (Christensen et al., 2004; Clarke et al., 1997; Mulle et al., 2000; Rodriguez-Moreno et al., 2000).”
BackgroundMetabotropic actions of kainate receptors modulating glutamate release
Falcón‐Moya, R., & Moreno, A. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108696 · Cited by 32
Johansen, T. N., Greenwood, J. R., Frydenvang, K., Madsen, U., & Krogsgaard‐Larsen, P. (2003) · Chirality · doi:10.1002/chir.10177 · Cited by 28
Clarke, V. R. J., & Collingridge, G. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.004 · Cited by 28
Self-citationValgeirsson, J., Nielsen, E. Ø., Peters, D., Varming, T., Mathiesen, C., Kristensen, A. S., & Madsen, U. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030428j · Cited by 27
Vignes, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00213-6 · Cited by 27
Xu, H., Wu, L., Zhao, M., Toyoda, H., Vadakkan, K. I., Jia, Y., Pinaud, R., & Zhuo, M. (2006) · Molecular Pain · doi:10.1186/1744-8069-2-29 · Cited by 28
“The modulation of γaminobutyric acid (GABA) release by presynaptic GluR5 KARs has been well reported in the hippocampus and cortex [2,15-22].”
BackgroundCarroll, F. Y., Finkelstein, D. I., Horne, M. K., Lawrence, A. J., Crawford, D. J., Paxinos, G., & Beart, P. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00720-4 · Cited by 26
Cryan, J. F., & Dev, K. K. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00013-6 · Cited by 27
Alushin, G. M., Jane, D. E., & Mayer, M. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.06.002 · Cited by 25
“…structure of the LY466195 complex Crystal structures have not yet been reported for ligands from the extensive series of decahydroisoquinolines which have been developed as glutamate receptor antagonists (Clarke et al., 1997; Ornstein et al., 1996; Ornstein et al., 1992; Weiss et al., 2006).”
BackgroundSiiskonen, H., Oikari, S., Korhonen, V., Pitkänen, A., Võikar, V., Kettunen, M. I., Hakumäki, J. M., Wahlfors, T., Pussinen, R., Penttonen, M., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.10.013 · Cited by 25
“Activation of kainate receptors has been described to downregulate GABAergic inhibition (Clarke et al., 1997; Rodriguez-Moreno et al., 1997).”
BackgroundBinns, K. E., Turner, J. P., & Salt, T. E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.045096 · Cited by 27
“On hippocampal neurones, the EC50 of ATPA for reduction of IPSPs has been shown to be 2 mM, and the dose used for functional studies was 10 mM (Clarke et al. 1997).”
BackgroundMethodResultInfluentialKask, K., Jerecìć, J., Zamanillo, D., Wilbertz, J. H., Sprengel, R., & Seeburg, P. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02599-3 · Cited by 27
The GABAA receptor agonist THIP is neuroprotective in organotypic hippocampal slice cultures
Kristensen, B. W., Noraberg, J., & Zimmer, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02550-2 · Cited by 25
Jin, X., & Smith, Y. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.017 · Cited by 26
“…has been reported that inhibition of GABAergic synaptic transmission by KA is mediated, at least in part, by activation of presynaptic KARs in the hippocampus (Clarke et al., 1997; Rodriguez-Moreno et al., 1997; Rodriguez-Moreno et al., 1998; Maingret et al., 2005) and SNc (Nakamura et al., 2003).”
BackgroundSynthesis and receptor binding affinity of new selective GluR5 ligands
Bunch, L., Johansen, T. H., Bräuner‐Osborne, H., Stensbøl, T. B., Johansen, T. N., Krogsgaard-Larsen, P., & Madsen, U. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00304-7 · Cited by 24
4-Alkylidenyl glutamic acids, potent and selective GluR5 agonists
Baker, S., Bleakman, D., Ezquerra, J., Ballyk, B. A., Deverill, M., Ho, K. H., Kamboj, R. K., Collado, I., Domı́nguez, C., Escribano, A., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00346-2 · Cited by 24
Self-citationPresynaptic kainate receptors are localized close to release sites in rat hippocampal synapses
Pinheiro, P. S., Rodrigues, R. J., Rebola, N., Xapelli, S., Oliveira, C. R., & Malva, J. O. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.007 · Cited by 25
Presynaptic lonotropic Receptors
Dorostkar, M. M., & Boehm, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_15 · Cited by 27
The Selective Activation of the Glutamate Receptor GluR5 by ATPA Is Controlled by Serine 741
Nielsen, M. M., Liljefors, T., Krogsgaard‐Larsen, P., & Egebjerg, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.19 · Cited by 24
“Surprisingly, (S)-ATPA, an AMPA analog in which the methyl group at the 5-position in the isoxazole ring is replaced by a tert-butyl group (Lauridsen et al., 1985), exhibits a strong preference for GluR5 compared with the AMPA receptors (Clarke et al., 1997; Stensbøl et al., 1999).”
BackgroundPentikäinen, O. T., Settimo, L., KEINÄNEN, K. P., & Johnson, M. S. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.013 · Cited by 24
Extracellular taurine in the substantia nigra: Taurine‐glutamate interaction
Dopico, J. G., Díaz, J. P., Alonso, T. J., González‐Hernández, T., Fuentes, R. C., & Rodríguez, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20108 · Cited by 23
“…involves presynaptic kainate receptors whose activation (with low kainate doses) often induces inhibitory effects (Chittajallu et al., 1996; Clarke et al., 1997; Lerma, 1997; Rodriguez-Moreno et al., 1997, 2000; Paternain et al., 1998; Frerking and Nicoll, 2000; Kamiya and Ozawa, 2000;…”
BackgroundBrown, J. T., Teriakidis, A., & Randall, A. D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.017 · Cited by 23
Cattaert, D., & Ray, D. L. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00384.x · Cited by 23
Partovi, D., & Frerking, M. E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.010 · Cited by 25
“... (EPSPs) at some synapses (Castillo et al., 1997; Cossart et al., 1998; Devries and Schwartz, 1999; Frerking et al., 1998; Kidd and Isaac, 1999; Li et al., 1999; Vignes and Collingridge, 1997); however, a more widespread finding has been that KAR activation, either by exogenous agonists or glutamate release, can le…”
Background[3H](2S,4R)‐4‐Methylglutamate: a novel ligand for the characterization of glutamate transporters
Apricó, K., Beart, P. M., Lawrence, A. J., Crawford, D. J., & O’Shea, R. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00337.x · Cited by 23
Glutamate Receptor Ion Channels: Activators and Inhibitors
Jane, D. E., Tse, H., Skifter, D. A., Christie, J. M., & Monaghan, D. T. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57083-4_17 · Cited by 24
Clarke, V. R. J., Collingridge, G. L., Lauri, S. E., & Taira, T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2327-12.2012 · Cited by 24
“, 2005; Sun and Dobrunz, 2006) and modulate GABA release onto CA1 pyramidal neurons (Clarke et al., 1997; RodríguezMoreno et al., 1997) in a heterosynaptic manner (Min et al.”
BackgroundSelf-citationJouhanneau, J.-S., Ball, S. M., Molnár, E., & Isaac, J. T. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.023 · Cited by 25
“Although kainate is selective for kainate receptors over AMPA receptors (AMPARs), it has significant activity at AMPARs at doses >1 mM (Clarke et al., 1997; Mulle et al., 2000).”
BackgroundIrvine, M. W., Costa, B. M., Dlaboga, D., Culley, G. R., Hulse, R. P., Scholefield, C. L., Atlason, P. T., Fang, G., Eaves, R. J., Morley, R., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201230z · Cited by 21
Self-citationPsychotropic and Neurotropic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 24
Nisticò, R., Amici-Dargan, S., Amici, M., Collingridge, G. L., & Bortolotto, Z. A. (2011) · Scientific Reports · doi:10.1038/srep00103 · Cited by 24
“Here we have demonstrated that activation of this KAR, using the highly selective GluK1 agonist ATPA 24 , together activation of a group I mGlu receptor is sufficient to induce a stable synaptic potentiation.”
Self-citationCell cycle-dependent regulation of kainate-induced inward currents in microglia
Yamada, J., Sawada, M., & Nakanishi, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.126 · Cited by 20
“Furthermore, ATPA (30 lM), a selective agonist for GluR5 [15], induced inward currents in the GMIR1 cells.”
BackgroundModulation of Transmitter Release Via Presynaptic Ligand-Gated Ion Channels
Schicker, K. W., Dorostkar, M. M., & Boehm, S. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801020106 · Cited by 23
Stensbøl, T. B., Jensen, H. S., Nielsen, B., Johansen, T. N., Egebjerg, J., Frydenvang, K., & Krogsgaard‐Larsen, P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00916-x · Cited by 20
Novel c-4 heteroaromatic kainoid analogues: a parallel synthesis approach
Baldwin, J. E., Fryer, A. M., & Pritchard, G. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00690-3 · Cited by 20
Thomas, N. K., Hawkins, L. M., Miller, J. C., Troop, H. M., Roberts, P., & Jane, D. E. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00124-5 · Cited by 20
Interneuron synaptopathy in developing rat cortex induced by the pro-inflammatory cytokine LIF
Engelhardt, M., Hamad, M. I. K., Jäck, A., Ahmed, K., König, J., Rennau, L.-M., Jamann, N., Räk, A., Schönfelder, S., Riedel, C., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.12.011 · Cited by 23
“To test this further, we made use of the findings that interneurons abundantly express kainate receptors containing the GluK1 subunit in the somatodendritic compartment, and that activating interneurons with the GluK1 agonist ATPA at 1 μM results in an increase of GABAergic inhibition in pyramidal neurons (Chattopadhy…”
A Review of Glutamate Receptors II: Pathophysiology and Pathology
Rousseaux, C. G. (2008) · Journal of Toxicologic Pathology · doi:10.1293/tox.21.133 · Cited by 20
Presynaptic Actions of General Anesthetics
Perouansky, M. A., & Hemmings, H. C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-322-4_21 · Cited by 21
Chew, L., Huang, F., Boutin, J., & Gallo, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29366 · Cited by 19
Acute Effects of Ethanol on Recombinant Kainate Receptors: Lack of Role of Protein Phosphorylation
Valenzuela, C. F., Cardoso, R. A., Lickteig, R. L., Browning, M. D., & Nixon, K. M. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03911.x · Cited by 19
Chamberlain, S. E. L., Jane, D. E., & Jones, R. S. G. (2011) · Hippocampus · doi:10.1002/hipo.20921 · Cited by 23
“The lack of effect of ATPA on holding current and of UBP302 on sEPSCs or KAr-mediated eEPSCs in our studies suggest that GluK1-(or GluK3) containing receptors are not present postsynaptically, or are not accessed by synaptically released glutamate.”
BackgroundResultInfluentialInterneurons and the ghost of the sea
Módy, I. (1998) · Nature Neuroscience · doi:10.1038/2151 · Cited by 20
Acute Effects of Ethanol on Kainate Receptors with Different Subunit Compositions
Valenzuela, C. F., & Cardoso, R. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38074-7 · Cited by 21
Savidge, J. R., Sturgess, N. C., Bristow, D. R., & Lock, E. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00202-0 · Cited by 18
Gelsomino, G., Menna, E., Antonucci, F., Rodighiero, S., Riganti, L., Mulle, C., Benfenati, F., Valtorta, F., Verderio, C., & Matteoli, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs026 · Cited by 20
“While at the postsynaptic level, these receptors mediate fast synaptic transmission and provide the structural basis for the control of network excitability, and at the presynapse, they play a major role in regulation of neurotransmitter release and short-term plasticity (Liu et al. 1994; Clarke et al. 1997; Rodriguez…”
BackgroundJuuri, J., Clarke, V. R. J., Lauri, S. E., & Taira, T. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00840.2009 · Cited by 20
Self-citationStructure, Function, and Regulation of the Kainate Receptor
Dhingra, S., Yadav, J., & Kumar, J. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-00793-4_10 · Cited by 15
Alcaide, A., Marconi, L., Marek, A., Haym, I., Nielsen, B., Møllerud, S., Jensen, M., Conti, P., Pickering, D. S., & Bunch, L. (2016) · MedChemComm · doi:10.1039/c6md00339g · Cited by 16
Grimonprez, A., Raedt, R., Dauwe, I., Mollet, L., Larsen, L. E., Meurs, A., Herdt, V. D., Wadman, W. J., Delbeke, J., Vonck, K. E. J., et al. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.09.013 · Cited by 21
Chew, L., Yuan, X. Q., Scherer, S. E., Qie, L., Huang, F., Hayes, W. P., & Gallo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101895200 · Cited by 17
Nielsen, P. A., & Liljefors, T. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1012414702198 · Cited by 16
Schubert, M., & Albrecht, D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301633 · Cited by 17
“ATPA is a substituted analogue of AMPA and binds to GLUK5 with high affinity and can also activate GLUK6/GLUK2 (Clarke et al, 1997).”
BackgroundWahl, P., Frandsen, A., Madsen, U., Schousboe, A., & Krogsgaard‐Larsen, P. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00108-7 · Cited by 15
Giardina, S. F., & Beart, P. M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00086-7 · Cited by 15
Metadata
- Authors
- Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D., & Bleakman, D.
- Affiliations
- University of Bristol (GB)
- Eli Lilly (United Kingdom) (GB)
- University of Edinburgh (GB)
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 599-603
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1637705010
- Cited by
- 416
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust
- Chinese Academy of Agricultural Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GluR5, kainate receptors, hippocampus, synaptic inhibition, atpA, glutamate receptors, epilepsy
- MeSH terms
- Animals, Cell Line, Cloning, Molecular, Hippocampus, Humans, Isoquinolines, Isoxazoles, Kainic Acid, Neural Inhibition, Propionates, Receptors, GABA-A, Synapses, Tetrazoles, Kainic Acid Receptors, Excitatory Amino Acid Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.